Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Spend $23.3M to Expand Scottish Facility; Will Become New Euro HQ

NEW YORK, May 2 (GenomeWeb News) - Invitrogen will spend £12.7 million ($23.3 million) to "consolidate" and "expand" its operations in Scotland, the Scottish Enterprise, the nation's main economic-development agency, said today.


Among the expansion is a plan to create a new global corporate research center in Inchinnan in the outskirts of Glasgow, which will also become Invitrogen's new European headquarters.

The move, which will be supported with a £4.3-million investment from Scotland's Deputy First Minister Nicol Stephen, will "potentially" create 45 new jobs and "safeguard" 555 existing Invitrogen positions in Scotland, the Scottish Enterprise said. Asked whether the jobs had been in jeopardy, a Scottish Enterprise spokesperson said Invitrogen could have expended anyplace in Europe, but since it chose Scotlandthose positions will remain "safeguarded."


Terms of the expansion call for Invitrogen to "amalgamate" its current manufacturing and product development sites across Scotlandinto the InchinnanBusinessPark.


The base, which will be moved into a 90,000-square-foot facility, will become the firm's European headquarters, and will have additional resources for R&D, sales, finance, legal, and customer services functions.


The move will "enable the company to meet increased business demand in a more cost effective way and has the potential for future expansion," Bernd Brust, vice president and general manager of Invitrogen Europe, said in a statement.


An Invitrogen spokesperson said construction on the new facility will begin this summer, and it is slated to open in the fall of 2007. Invitrogen will finish transferring staff and operations at that time, the spokesperson added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.